Mrinal Patnaik is a Hematology physician affiliated with Mayo Clinic. OpenAlex indexes 1,221 publications with 19,721 citations (h-index 73); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 19 Aug 2020.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
78%SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor78%Remdesivir100%Part B, office-administered≥11 patientsDermatology
16.8%Corticosteroid15.8%Methylprednisolone sodium succinate100%Part B, office-administered≥12 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor1%Acyclovir100%Part D<11 patientsCancer & immunology
4.4%Kinase inhibitor1.8%Jakafi100%Part D<11 patientsInterferon alpha1.6%Pegasys100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
Mayo Clinic Rochester
FY2026$427,131R01CA272496 - Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
Mayo Clinic Rochester
FY2025$427,131R01CA272496 - Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
Mayo Clinic Rochester
FY2024$405,775R01CA272496
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
American Journal of Hematology
2022 - Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population
Hepatology Communications
2021
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Joseph Antin, MD
Boston University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”